GloGlo
YC W24San Francisco, US Β· Founded 2024 Β· 3 employees Β· Hiring Β· 8 known investors
14.ai builds software that automates the core operations of e-commerce brands, handling customer acquisition, order fulfillment, and support with minimal human intervention, and uses the platform to operate its own direct-to-consumer business.
Also known as 14.ai Β· Markprompt Β· GloGlo Β· gloglo.com Β· MOTIF LAND INC.
Founders & leadershipΒ· Y Combinator alumni (W24)
GloGlo was founded in 2024 by Marie Schneegans and Michael Fester.
Investors Β· 8
.png)
Also in the syndicate Β· 4
Company profile
researched Aug 2026GloGlo is a San Francisco consumer health company founded in 2024 and part of Y Combinator's Winter 2024 batch, with a team size of 3 as listed by YC. Its stated mission is to "cure diabetes, and help every person with diabetes stay healthy until we do," and it positions itself as a consumer health brand for diabetics and the glucose-conscious. Its first products are GloGlo Energy Gummies (fast-acting glucose gummies for exercise, daily energy, and treating low blood sugar) and a GloGlo AI glucose companion that converts continuous glucose data into personalized insights and guidance. [0][1][4][5][7]
The company previously operated as 14.ai, described in its YC launch post as an AI-native customer service agency serving e-commerce, mobile app, fintech and healthcare companies, with named customers including AI glasses maker Brilliant, supplement brand Sperm Worms, Nordic lighting company Creative Lighting, and skincare brand Yon-Ka. In that model, San Francisco-based AI engineers operated proprietary automation software to resolve support tickets end to end (verifying purchases, generating shipping labels, triggering refunds), offering a 7-day free trial and going live within hours. GloGlo was launched by 14.ai as "the world's first autonomous consumer brand," owned and operated by 14.ai as a demonstration of an autonomously run B2C company. A June 2026 GloGlo post states that the team built 14.ai, an "AI studio for autonomous consumer brands," before focusing fully on GloGlo. [0][1][2][6]
The GloGlo mobile app, published on Google Play by MOTIF LAND INC. (2261 Market St, San Francisco) under the package id ai.fourteen.gloglo, lets users connect health data, set a Time in Range goal, ask questions by voice or chat, and receive daily AI coaching and pattern insights, plus community features. The listing carries in-app purchases, shows 10+ downloads, and was updated 2026-08-09; the app is labeled educational only and explicitly does not provide medical advice, diagnosis, treatment, or insulin dosing. [3]
Founding story
Co-founders Michael Fester and Marie Schneegans, a married founder duo per TechCrunch coverage referenced by YC, moved to the United States from France as second-time founders. Michael Fester has lived with Type 1 diabetes for 17 years, previously created Glucool, an early diabetes health app, and co-founded Snips, an AI voice platform acquired by Sonos; he studied maths at Cambridge. The founders, both active runners, say existing quick-glucose products were chalky, overly medical, or made with ingredients they disliked, which motivated fast-acting glucose gummies designed as a modern consumer product. The team cites backgrounds from Cambridge, UC Berkeley and EPFL and Forbes 30 Under 30 recognition. [0][1][6][7]
Business model
Consumer health brand combining a physical product (glucose gummies, including limited-edition collaboration jars with creators and advocates) with a mobile app offering AI coaching, sold directly to consumers; the Google Play listing indicates in-app purchases. Earlier, under the 14.ai brand, the company operated a B2B service model: an AI-native customer service agency that took over brands' support ticket operations for e-commerce, mobile app, fintech and healthcare customers, beginning with a 7-day free trial. [0][1][3][5][6]
Product sales of glucose gummies plus app monetization through in-app purchases; the prior 14.ai business charged brands for outsourced, AI-operated customer service delivered as a managed agency service. [0][1][3][6]
Traction
YC lists the company as active with a team size of 3. The Google Play app listing shows 10+ downloads and an update on 2026-08-09. Under 14.ai, the company stated that every onboarded customer repurposed its support team before the free trial finished, and named Brilliant, Sperm Worms, Creative Lighting and Yon-Ka as customers; a hiring page states a goal of reaching $10M ARR by the end of 2026 and cites TechCrunch coverage from March 2026. [0][1][3][6]
Latest developments
June 2026: GloGlo published posts explaining its rationale (2026-06-22), announced the GloGlo mobile app (2026-06-29), and described its internal and product AI use, including the planned GloGlo AI Agent and the Riva Run game (2026-06-30). The Google Play app listing was updated on 2026-08-09 with expanded health-data connections and improved daily tracking. YC's Consumer Health Services directory page dated August 2026 lists GloGlo as active with 3 employees. [2][3][4][5]
βΈFull profile β market position, technology, go-to-market, geography, history, risks & controversies
Market position
An early-stage Y Combinator-backed consumer health startup (3 employees) listed among YC's Consumer Health Services companies, differentiating on lived diabetes experience and consumer-product design in a category it describes as clinical and hard to understand. The GloGlo app carried 10+ downloads on Google Play as of the listing. [0][1][3][4][7]
Positions its gummies against glucose tablets on quality-of-life and consumption experience (fast-acting, portable, non-chalky, non-clinical), and pairs the physical product with an AI companion, coaching, community, education and playful content such as the Riva Run game, aiming for an ecosystem rather than a single product. Founder lived experience with Type 1 diabetes for 17 years and a prior diabetes app (Glucool) are cited as design inputs. In the 14.ai business, differentiation was framed against traditional BPOs' headcount-based, legacy-CRM approach via hours-long onboarding, agentic resolution and 24/7 coverage. [0][1][2][7]
Technology
A consumer mobile app (iOS/Android) built around an AI agent that ingests connected health data, including continuous glucose data, plus food, movement, sleep and stress signals, and returns conversational (voice or chat) answers, daily coaching, and pattern detection oriented to a user's Time in Range goal. The team also applies AI internally across engineering, creator operations, retail outreach, content workflows and logistics, using an in-house dashboard for creator operations. The company states AI in health should be personalized, transparent, privacy-first and human-centered, referencing the co-founder's prior work on privacy-first AI systems; the Play listing states no data is shared with third parties and data is encrypted in transit. Its earlier 14.ai stack was agentic support automation that could verify purchases, generate shipping labels and trigger refunds, with human interventions fed back into the agents. [0][1][2][3]
Go-to-market
Direct-to-consumer via gloglo.com and app stores, supported by content marketing (a Stories blog profiling diabetes advocates and creators), creator collaborations and limited-edition jars (e.g., with actor Austin Basis and creators Ashton Romero and Nikki), community features in the app, and retail outreach. Under 14.ai, go-to-market was founder-led B2B sales with discovery calls, demos and a 7-day free trial, with a Founding GTM role targeting DTC brands on Shopify and TikTok Shop. [0][1][2][5][6]
People with Type 1 and other diabetes, the glucose-conscious, and high-performance athletes seeking rapid carbohydrate intake; app users tracking Time in Range. Under the earlier 14.ai model, target customers were B2C and DTC brands on Shopify and TikTok Shop plus established e-commerce, mobile app, fintech and healthcare companies with high support volumes. [0][1][6][7]
Geography
Headquartered in San Francisco, California (developer address listed as 2261 Market St, San Francisco, CA 94114), with an office house in the city; the founders relocated from France. Job listings are for San Francisco with one remote-US option. [0][1][3][6][7]
History
Founded in 2024 and admitted to Y Combinator's Winter 2024 batch (primary partner Tom Blomfield). The team previously launched Markprompt, an AI product for customer support, and then 14.ai, an AI-native customer service agency for B2C brands, which the founders described as an AI studio for autonomous consumer brands. 14.ai launched GloGlo as an owned-and-operated consumer brand, and the team subsequently shifted its full focus to GloGlo. In March 2026 the company's 14.ai work was covered by TechCrunch; GloGlo began publishing brand stories in June 2026, announced its mobile app on 2026-06-29, and the Google Play app listing was updated on 2026-08-09. [0][1][2][3][5][6]
Risks & controversies
The company changed business focus from the 14.ai B2B customer service agency to the GloGlo consumer health brand, and public hiring material still describes the 14.ai agency and its $10M ARR goal, indicating positioning in flux. The product touches sensitive health data: the app discloses collection of personal info and health and fitness data, and the company states GloGlo is educational only and does not provide medical advice, diagnosis, treatment or insulin-dosing recommendations. No disclosed funding amounts are available in the sources. [0][1][2][3][6]
Compiled by commissioned research from 8 cited public sources β announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed β not independently audited.
Images
Timeline Β· 5
launches, deals, and filingsThe Android app (package ai.fourteen.gloglo, developer MOTIF LAND INC.) was updated with additional health-data connections, improved daily tracking and logging, and reliability fixes.
GloGlo published a story announcing the launch of its mobile app, extending beyond the fast-acting glucose gummies.
A YC job listing references a TechCrunch article dated 2026-03-02 about the married founder duo's company 14.ai replacing customer support teams at startups.
YC launch post introduced 14.ai as an AI-native customer service agency and simultaneously announced GloGlo, described as the world's first autonomous consumer brand, offering rapid glucose gummies owned and operated by 14.ai.
GloGlo is listed in the Y Combinator directory as a Winter 2024 batch company, founded 2024, based in San Francisco, with primary partner Tom Blomfield.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
In the news
AI Customer Support Market: 46 Funding Deals (Full List 2024-2026) (2026) β New Market Pitchnewmarketpitch.com Β· Jul 2026βΈResearch sources Β· 8
primary sources listed
- 14.ai: AI engine powering autonomous brands starting with gloglo.com | Y Combinatorycombinator.com Β· web
8 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does GloGlo do?
- GloGlo (formerly 14.ai) sells fast-acting glucose gummies and an AI glucose companion app for diabetics.
- Who founded GloGlo?
- GloGlo was founded by Marie Schneegans, Michael Fester in 2024.
- Who are GloGlo's investors?
- GloGlo's investors include Y Combinator, Base Case Capital, General Catalyst, SV Angel.
- Where is GloGlo headquartered?
- GloGlo is headquartered in San Francisco, US.